Lonza is in the process of establishing a strategic biomanufacturingfacility in China. Given Lonza’s extensive experience in setting up,running an d developing new state-of-the-art biologic sites across theglobe, Lonza an d GE Healthcare signed an agreement on 10 December
2018 under which GE Healthcare will deliver a biologics facility toLonza in Guangzhou （CN）. The facility is part of a larger biomanufacturinginitiative between GE Healthcare an d Guangzhou DevelopmentDistrict （GDD） – Sino-Singapore Guangzhou Knowledge City.The new facility will give Lonza Pharma Biotech & Nutrition （LPBN） astrategic ba
automation platforms for clinical an d early-commercial supply.
